Enanta Pharmaceuticals Inc
ENTA
$11.10-3.23%
End of day · as of Oct 17, 2026, 8:00 AM ET
Mkt cap
$328.00M
EV/Sales
4.53
P/E ratio
N/A
FY2025 Revenue
$65.32M
EPS (9mo ended 2026-06-30)
$-1.54
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-125.36%
Beta
0.99
Div yield
N/A
Sector
Healthcare
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
Use this ENTA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ENTA income, balance, and cash tables.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company in the Healthcare sector.
Latest cached Enanta Pharmaceuticals Inc (ENTA) revenue for Sep 30, 2025 was $65.3M. Net income was -$81.9M. Statements: https://lician.com/financials/enta
Enanta Pharmaceuticals Inc (ENTA) market capitalization is $328.0M on the latest cached snapshot.
Enanta Pharmaceuticals Inc (ENTA) cached previous close $11.47; day range $11.10 – $11.65; volume 213,437. Session quote: https://lician.com/quote/enta
Enanta Pharmaceuticals Inc (ENTA) latest cached earnings event is "ENTA earnings" on Aug 10, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ENTA filing is 8-K · Jul 2, 2026. Filings: https://lician.com/sec/enta